Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007196
Chunk: 114

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 114
---
4.99%, which does not permit the selling shareholder 
 to exercise that portion of the warrants that would result in the selling shareholder and its affiliates owning, after exercise, a number     
 of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts and percentages in the table do not give effect to       
 the 4.99% beneficial ownership limitation, if applicable. Iroquois Capital Management L.L.C. is the investment manager of Iroquois Master     
 Fund, Ltd. Iroquois Capital Management, LLC has voting control and investment discretion over securities held by Iroquois Master Fund.        
 As Managing Members of Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page make voting and investment decisions on behalf        
 of Iroquois Capital Management, LLC in its capacity as investment manager to Iroquois Master Fund Ltd. As a result of the foregoing, Mr.      
 Abbe and Mrs. Page may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934,      
 as amended) of the securities held by Iroquois Capital Management and Iroquois Master Fund. The principal business address of Iroquois        
 Master Fund Ltd. is c/o Iroquois Capital Management, LLC, 2 Overhill Road, Suite 400, Scarsdale, NY 10583.                                    |

| 62 |

| (12) | The selling shareholder holds Replacement Warrants issued by us                                                                                
 which entitle the selling shareholder to purchase an aggregate of 28,500,000 Ordinary Shares                                                   
 (in the form of Depositary Shares) which we are registering hereby. The warrants are subject to a beneficial ownership limitation of 4.99%,    
 which does not permit the selling shareholder to exercise that portion of the warrants that would result in the selling shareholder and        
 its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts and       
 percentages in the table do not give effect to the 4.99% beneficial ownership limitation, if applicable. Kingsbrook Partners LP, or Kingsbrook 
 Partners, is the investment manager of Kingsbrook Opportunities Master Fund LP, or Kingsbrook Opportunities, and consequently has voting       
 control and investment discretion over securities held by Kingsbrook Opportunities. Kingsbrook Opportunities GP LLC, or Opportunities          
 GP, is the general partner of Kingsbrook Opportunities and may be considered the beneficial owner of any securities deemed to be beneficially